داروسازی اکسیر
دلر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Cash Flow
AGM
Interim
2026/06/08 Fiscal Year 2026/03/2012 Month | 2026/05/19 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 13.127 Trillion | 13.169 Trillion | |
Income Taxes Paid | -2.453 Trillion | -2.453 Trillion | |
Net Cash Flow from Operating Activities | 10.674 Trillion | 10.716 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 7.52 Billion | 7.52 Billion | |
Purchases of Property, Plant and Equipment | -1.846 Trillion | -1.846 Trillion | |
Proceeds from Sale of Short-Term Investments | 42.405 Billion | - | |
Cash Received from Income on Other Investments | 424 Million | 424 Million | |
Net Cash Flow from Investing Activities | -1.796 Trillion | -1.838 Trillion | |
Net Cash Flow before Financing Activities | 8.878 Trillion | 8.878 Trillion | |
Proceeds from Sale of Treasury Shares | 43.581 Billion | 43.283 Billion | |
Purchases of Treasury Shares | -85.986 Billion | -85.986 Billion | |
Cash Received from Borrowings | 16.434 Trillion | 16.434 Trillion | |
Repayments of Borrowings (Principal) | -19.619 Trillion | -19.619 Trillion | |
Interest Paid on Borrowings | -3.521 Trillion | -3.521 Trillion | |
Dividends Paid | -2.418 Trillion | -2.418 Trillion | |
Net Cash Flow from Financing Activities | -9.166 Trillion | -9.166 Trillion | |
Net Increase (Decrease) in Cash | -288.339 Billion | -288.339 Billion | |
Cash at Beginning of Period | 1.06 Trillion | 1.06 Trillion | |
Effect of Exchange Rate Changes | 197.581 Billion | 197.581 Billion | |
Cash at End of Period | 1.257 Trillion | 1.257 Trillion | |
Non-Cash Transactions | 7.21 Trillion | 7.21 Trillion |